Paulina Flis
About me
Paulina works as a specialist physician in Clinical Pharmacology at Karolinska University Hospital. The daily work include working with drug information, therapeutic drug monitoring, clinical trials ( Klinisk Farmakologisk Prövningsenhet (KFP)) and also part time work at the Intestinal Failure Unit. (Mottagning Tarmsvikt Solna).
Since januari 2024 PhD student with main supervisor Annika Bergquist, the thesis focuses on different aspects of drug therapy for patients with liver disease.
Since 2021 also a member of the therapy group for Gastrointestinal Diseases for the Stockholm Region's Pharmaceutical Committee and one the workers union representative in Clinical Pharmacology, Karolinska University hospital.
Research
Paulinas research focuses on medications for liver disease, both on pharmacodynamics (the drugs effects on the body) and pharmacokinetics (the body's effects on the drug). The studies investigates commonly used medications and cancer risk in primary sclerosing cholangitis, as well as the metabolism of drugs in liver cirrhosis. The research includes both pharmacoepidemiological studies and a prospective clinical trial and the research is conducted at Karolinska University Hospital. For more information about Annika Bergquist's research group, see Annika Bergquist group | Karolinska Institutet.
Teaching
Participate since 2020 in teaching the Clinical Pharmacology course in the M.D. at Karolinska Institute.
All other publications
- Review: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2024;59(7):821-829
- Letter: CUTIS. 2019;103(6):E20-E21
Employments
- Specialist physician in Clinical Pharmacology, Clinical Pharmacology, Karolinska University Hospital, 2024-
- Specialist physician in Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, 2024-2027
- Phd Student, Department of Medicine, Huddinge, Karolinska Institutet, 2024-2025
- Resident in Clinical Pharmacology, Clinical Pharmacology, Karolinska University Hospital, 2019-2024
Committee work
- Member, Divisional representative (division of clinical pharmacology) of the Medical Association of the Karolinska University hospital, 2021-
- Member, Therapy group for Gastrointestinal Diseases in the Stockholm Region's Pharmaceutical Committee, Region Stockholm, 2021-
Conference/event participation
- Poster presenter of own accepted abstract, European Crohn and Colitis organization ECCO 2024, Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review, 2024
- Poster presenter of own accepted abstract, ENTIS/OTIS meeting 2024, Monoclonal antibodies during breastfeeding - Challenges with Relative Infant Dose (RID), 2024